Within the Hearing Screening Diagnostic Devices Market , audiometers hold the largest share, reflecting their essential role in basic hearing assessment. According to the MRFR report, audiometers are used to measure hearing sensitivity across a range of frequencies and are the primary tool for diagnosing hearing loss. They are widely used in hospitals, clinics, and schools for screening and diagnostic purposes. The audiometer segment is expected to maintain its dominance due to the high volume of tests performed annually.
While audiometers lead, otoacoustic emission (OAE) equipment and auditory brainstem response (ABR) equipment are the fastest-growing segments. OAE equipment is used to measure sounds emitted by the inner ear in response to a stimulus. It is particularly useful for newborn hearing screening and for differentiating between sensorineural and conductive hearing loss. The increasing implementation of universal newborn hearing screening programs is driving the growth of the OAE segment.
ABR equipment measures the electrical activity of the auditory nerve and brainstem in response to sound. It is used for diagnostic testing in infants and difficult-to-test patients, as well as for intraoperative monitoring during ear surgery. The ABR segment is growing due to its utility in neurodiagnostic applications and the increasing prevalence of auditory neuropathy spectrum disorder.
Tympanometers are another important segment, used to assess middle ear function and detect conditions such as otitis media. The tympanometer segment is expected to grow steadily, driven by the high prevalence of middle ear infections in children.
The market is also segmented by technology, with digital audiometers rapidly replacing analog devices. Digital devices offer greater accuracy, ease of use, and data management capabilities. The integration of software and connectivity features is enabling seamless integration with electronic health records (EHRs) and telehealth platforms.
The growth of the OAE and ABR segments is driven by the increasing focus on early detection and the need for objective, non-invasive testing methods. The expansion of newborn hearing screening programs and the growing awareness of auditory processing disorders are also contributing factors. As technology continues to advance, these segments are expected to capture an increasing share of the market.
